PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | -20.0% | 6,850 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $25,000 | -40.5% | 6,850 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $42,000 | -16.0% | 6,850 | +9.6% | 0.01% | -9.1% |
| Q4 2021 | $50,000 | -46.2% | 6,250 | 0.0% | 0.01% | -52.2% |
| Q3 2021 | $93,000 | +19.2% | 6,250 | 0.0% | 0.02% | +15.0% |
| Q2 2021 | $78,000 | +122.9% | 6,250 | -19.4% | 0.02% | +100.0% |
| Q1 2021 | $35,000 | -7.9% | 7,750 | -56.6% | 0.01% | -16.7% |
| Q4 2020 | $38,000 | +660.0% | 17,850 | +693.3% | 0.01% | +500.0% |
| Q3 2020 | $5,000 | +66.7% | 2,250 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $3,000 | +200.0% | 2,250 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $5,000 | -50.0% | 2,250 | -30.8% | 0.00% | -50.0% |
| Q3 2019 | $10,000 | -47.4% | 3,250 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $19,000 | – | 3,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |